Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
Guadalupe M, Pollock BH, Westbrook S, Redding S, Bullock D, Anstead G, Agan BK, Marconi VC, Barbieri S, Sankar V, Rebeles J, Flahive Y, Schoolfield J, Wang L, Lei X, Dow D, Yeh CK, Dang H, Infante AJ, Gao SJ.
Guadalupe M, et al. Among authors: wang l.
J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):83-90. doi: 10.1097/QAI.0b013e3181fdc928.
J Acquir Immune Defic Syndr. 2011.
PMID: 21084997
Free PMC article.